S.Korea to resume wider use of AstraZeneca coronavirus vaccine, exclude people under 30 | Inquirer News

S.Korea to resume wider use of AstraZeneca coronavirus vaccine, exclude people under 30

/ 02:19 PM April 11, 2021

S.Korea to resume wider use of AstraZeneca coronavirus vaccine, exclude people under 30

FILE PHOTO: South Korean senior citizens receive their first dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination centre in Seoul, South Korea April 1, 2021. Chung Sung-Jun/Pool via REUTERS

SEOUL — South Korean authorities said on Sunday they will move ahead with a second-quarter coronavirus vaccination drive starting on Monday as planned after deciding to continue using AstraZeneca’s vaccine for all eligible people 30 years old or over.

South Korea had said on Wednesday it would temporarily suspend providing AstraZeneca’s COVID-19 vaccine to people below 60 amid a European review over cases of blood clotting in adults.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: AstraZeneca, COVID-19, COVID-19 Vaccine, South korea

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.